Trade CVKD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cadrenal Therapeutics, Inc. (CVKD) is trading at US$1.07, down 4.46% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$5.74M. Over the past 52 weeks, CVKD has traded between US$1.00 and US$14.64. On Syfe you can trade CVKD with $0 commission and add it to your watchlist.
| Previous close | US$1.12 |
|---|---|
| Market cap | US$5.74M |
| 52-week range | US$1.00 – US$14.64 |
| Volume | 113.7K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.
Year: 2023
Cadrenal Therapeutics Prices Private Placement for Up to $8.8 Million
Jul 1, 7:55 AM · MT Newswires
Cadrenal Therapeutics to Seek US FDA's Rare Pediatric Disease Designation for Tecarfarin to Treat Children With Kawasaki Disease
Jun 18, 1:53 PM · MT Newswires
Cadrenal Therapeutics, Inc. (CVKD) stock is trading at US$1.07, -4.46% from the previous close of US$1.12.
The market cap for Cadrenal Therapeutics, Inc. (CVKD) stock is approximately US$5.74M.
The 52-week high for Cadrenal Therapeutics, Inc. (CVKD) stock is US$14.64.
The 52-week low for Cadrenal Therapeutics, Inc. (CVKD) stock is US$1.00.
Cadrenal Therapeutics, Inc. (CVKD) does not currently pay a dividend.
Stay on top of CVKD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
